使用Kowa DR-1α泪液干涉仪在健康受试者和干眼患者中自动测量泪河高度
研究纳入49名受试者共69眼(36名健康志愿者,33例水液缺乏型干眼患者),采用Kowa DR-1α泪液干涉仪与新型软件及前节扫频源OCT测量下泪河高度,评估重复性与再现性及两设备一致性。结果显示干涉仪测量泪河高度与SS-OCT同样可靠,且干涉法泪河高度与Schirmer试验值显著相关。
要点
- DR-1α系统重复性CV<2.0%,健康者组内、组间及会话间CV分别≤9.6%、≤4.5%、≤4.4%。
- 水液缺乏型干眼患者相应CV分别≤16.8%、≤9.8%、≤10.3%,ICC≥0.48。
- 干涉法泪河高度与Schirmer试验值在健康者(β=0.59,P<0.001)和干眼患者(β=0.47,P=0.017)中均显著相关。
核心结论
- 泪液干涉法测量泪河高度与SS-OCT同样可靠,DR-1α可能有助于干眼病诊断及亚型鉴别。
研究设计与样本
- 纳入49名受试者(36名健康志愿者,33例水液缺乏型干眼患者)共69眼,平均年龄50.0±14.0岁。
- 由两名观察者分别使用DR-1α泪液干涉仪配合新型软件及前节扫频源OCT测量下泪河高度。
- 基于受试者内标准差、变异系数和组内相关系数评估操作者内重复性及操作者间和会话间再现性。
- 采用回归和Bland-Altman分析评估两设备间的一致性。
主要发现
- DR-1α系统重复性CV<2.0%。
- 健康受试者DR-1α测量操作者内重复性、操作者间再现性和会话间再现性CV分别≤9.6%、≤4.5%和≤4.4%,相应ICC均≥0.87。
- 水液缺乏型干眼患者DR-1α测量操作者内重复性、操作者间再现性和会话间再现性CV分别≤16.8%、≤9.8%和≤10.3%,相应ICC均≥0.48。
- Bland-Altman图提示两设备间一致性高。
- Schirmer试验值与干涉法泪河高度在健康受试者(β=0.59,P<0.001)和水液缺乏型干眼患者(β=0.47,P=0.017)中均显著相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop and assess a method for quantitation of lower tear meniscus height (TMH) with the Kowa DR-1α tear interferometer. METHODS: Sixty-nine eyes of 49 men and 20 women (36 healthy volunteers, 33 patients with aqueous-deficient dry eye [ADDE]; mean age ± SD, 50.0 ± 14.0 years) were enrolled. TMH of each subject was measured by two observers both with DR-1α and newly developed software and with anterior-segment swept-source optical coherence tomography (SS-OCT). Intraoperator repeatability and interoperator and intersession reproducibility of measurements were assessed based on the within-subject SD (Sw), coefficient of variation (CV), and intraclass correlation coefficient (ICC). Agreement between the two devices was assessed by regression and Bland-Altman analysis. RESULTS: The CV for system repeatability of DR-1α was <2.0%. The CV for intraoperator repeatability and interoperator and intersession reproducibility for DR-1α measurements was ≤9.6%, ≤4.5%, and ≤4.4% in healthy subjects, respectively, and ≤16.8%, ≤9.8%, and ≤10.3% in ADDE patients. All corresponding ICC values were ≥0.87 in healthy subjects and ≥0.48 in ADDE patients. Bland-Altman plots indicated a high level of agreement between the two devices. Schirmer test value was significantly correlated with interferometric TMH in both healthy subjects (β = 0.59, P < 0.001) and ADDE patients (β = 0.47, P = 0.017). CONCLUSIONS: Tear interferometry allows measurement of TMH as reliably as does SS-OCT. DR-1α may inform not only the diagnosis of dry eye disease but also identification of disease subtype.
引用
- Arita R, Yabusaki K, Hirono T, et al. Automated Measurement of Tear Meniscus Height with the Kowa DR-1α Tear Interferometer in Both Healthy Subjects and Dry Eye Patients. Invest Ophthalmol Vis Sci. 2019. PMID: 31091317. doi:10.1167/iovs.18-24850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。